Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.

Nicholas Reed, Patricia Pautier, Elizabeth Avall-Lundqvist, Chel-Hun Choi, Andreas du Bois, Michael Friedlander, Anthony Fryles, Ganessan Kichenadasse, Diane Provencher, Isabelle Ray-Coquard

    Research output: Contribution to journalReview articlepeer-review

    25 Citations (Scopus)

    Abstract

    Small cell carcinomas of the ovary are uncommon and account for less than 1% of ovarian cancers. They were first recognized in 1979, and a number of reports appeared during the next 2 decades. They are highly aggressive tumors and usually carry a poor prognosis, although this may reflect that most are diagnosed at advanced stage; however, those diagnosed as stage 1A have only 30% to 40% of long-Term survivors. More reports followed extending our experience in the diagnosis and management of these rare cancers. The classification is described below and shown in Table 1, but a revision is expected to be published from the World Health Organization in 2014.

    Original languageEnglish
    Pages (from-to)S30-S34
    Number of pages4
    JournalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    Volume24
    Issue numberS3
    DOIs
    Publication statusPublished - Nov 2014

    Keywords

    • Chemotherapy
    • Hypercalcaemia
    • Pulmonary type
    • Radiation therapy
    • Rare cancers
    • Small cell carcinoma ovary
    • Surgery

    Fingerprint Dive into the research topics of 'Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers.'. Together they form a unique fingerprint.

    Cite this